Skip to main content
Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
25.50
+3.04 (13.54%)
At close: Mar 9, 2026, 4:00 PM EDT
26.20
+0.70 (2.75%)
After-hours: Mar 9, 2026, 7:53 PM EDT

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $15.00K in the quarter ending September 30, 2025, a decrease of -55.88%. This brings the company's revenue in the last twelve months to $41.00K, down -34.92% year-over-year. In the year 2024, Lyell Immunopharma had annual revenue of $61.00K, down -53.08%.

Revenue (ttm)
$41.00K
Revenue Growth
-34.92%
P/S Ratio
13,212.70
Revenue / Employee
$137
Employees
300
Market Cap
541.72M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202461.00K-69.00K-53.08%
Dec 31, 2023130.00K-84.55M-99.85%
Dec 31, 202284.68M74.03M695.15%
Dec 31, 202110.65M2.89M37.31%
Dec 31, 20207.76M7.10M1,080.52%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Vanda Pharmaceuticals 216.11M
Century Therapeutics 113.34M
Zevra Therapeutics 84.39M
Entrada Therapeutics 25.42M
Altimmune 41.00K
Revenue Rankings

LYEL News

More News